Clinical Trial: FASD Prevention R33

U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07828275) titled 'FASD Prevention R33' on Sept. 11.

Brief Summary: This R33 application proposes to adapt and test an evidence-based behavioral intervention to decrease polysubstance use (i.e., alcohol and tobacco/cannabis) during pregnancy and lactation and prevent adverse clinical outcomes, including fetal alcohol spectrum disorder (FASD) in South Africa (SA). SA has a long history of social and health disparities, resulting in the world's highest rate of FASD (111.1 per 1,000), where lifelong negative cognitive and physical effects result from prenatal alcohol exposure. FASD is completely preventable if women do not drink during pregnancy. Prenat...